Literature DB >> 26187936

Essential Fatty Acid Deficiency in 2015: The Impact of Novel Intravenous Lipid Emulsions.

Leah Gramlich1, Liisa Meddings2, Cathy Alberda3, Sanit Wichansawakun4, Sarah Robbins5, David Driscoll6, Bruce Bistrian7.   

Abstract

The fatty acids, linoleic acid (18:2ω-6) and α-linolenic acid (18:3ω-3), are essential to the human diet. When these essential fatty acids are not provided in sufficient quantities, essential fatty acid deficiency (EFAD) develops. This can be suggested clinically by abnormal liver function tests or biochemically by an elevated Mead acid and reduced linoleic acid and arachidonic acid level, which is manifested as an elevated triene/tetraene ratio of Mead acid/arachidonic acid. Clinical features of EFAD may present later. With the introduction of novel intravenous (IV) lipid emulsions in North America, the proportion of fatty acids provided, particularly the essential fatty acids, varies substantially. We describe a case series of 3 complicated obese patients who were administered parenteral nutrition (PN), primarily using ClinOleic 20%, an olive oil-based lipid emulsion with reduced amounts of the essential fatty acids, linoleic and α-linolenic, compared with more conventional soybean oil emulsions throughout their hospital admission. Essential fatty acid profiles were obtained for each of these patients to investigate EFAD as a potential cause of abnormal liver enzymes. Although the profiles revealed reduced linoleic acid and elevated Mead acid levels, this was not indicative of the development of essential fatty acid deficiency, as reflected in the more definitive measure of triene/tetraene ratio. Instead, although the serum fatty acid panel reflected the markedly lower but still adequate dietary linoleic acid content and greatly increased oleic acid content in the parenteral lipid emulsion, the triene/tetraene ratio remained well below the level, indicating EFAD in each of these patients. The availability and use of new IV lipid emulsions in PN should encourage the clinician to review lipid metabolism based on the quantity of fatty acids provided in specific parenteral lipid emulsions and the expected impact of these lipid emulsions (with quite different fatty acid composition) on measured fatty acid profiles.
© 2015 American Society for Parenteral and Enteral Nutrition.

Entities:  

Keywords:  fatty acids; lipids; nutrition; parenteral nutrition; research and diseases

Mesh:

Substances:

Year:  2015        PMID: 26187936     DOI: 10.1177/0148607115595977

Source DB:  PubMed          Journal:  JPEN J Parenter Enteral Nutr        ISSN: 0148-6071            Impact factor:   4.016


  9 in total

Review 1.  Redefining essential fatty acids in the era of novel intravenous lipid emulsions.

Authors:  Lorenzo Anez-Bustillos; Duy T Dao; Gillian L Fell; Meredith A Baker; Kathleen M Gura; Bruce R Bistrian; Mark Puder
Journal:  Clin Nutr       Date:  2017-07-08       Impact factor: 7.324

2.  Metabolomic Markers of Essential Fatty Acids, Carnitine, and Cholesterol Metabolism in Adults and Adolescents with Phenylketonuria.

Authors:  Bridget M Stroup; Nivedita Nair; Sangita G Murali; Katarzyna Broniowska; Fran Rohr; Harvey L Levy; Denise M Ney
Journal:  J Nutr       Date:  2018-02-01       Impact factor: 4.798

3.  Characterization of Fatty Acid Profiles in Infants With Intestinal Failure-Associated Liver Disease.

Authors:  Meredith A Baker; Paul D Mitchell; Alison A O'Loughlin; Alexis K Potemkin; Lorenzo Anez-Bustillos; Duy T Dao; Gillian L Fell; Kathleen M Gura; Mark Puder
Journal:  JPEN J Parenter Enteral Nutr       Date:  2017-12-06       Impact factor: 4.016

4.  Two-Year Neurodevelopment and Growth Outcomes for Preterm Neonates Who Received Low-Dose Intravenous Soybean Oil.

Authors:  Margaret L Ong; Isabell B Purdy; Orly L Levit; Daniel T Robinson; Tristan Grogan; Martiniano Flores; Kara L Calkins
Journal:  JPEN J Parenter Enteral Nutr       Date:  2017-12-19       Impact factor: 4.016

5.  Fermentable fibers induce rapid macro- and micronutrient depletion in Toll-like receptor 5-deficient mice.

Authors:  Rachel M Golonka; Beng San Yeoh; Yaqi Li; Piu Saha; Ahmed A Abokor; Xi Cheng; Xia Xiao; Darshan Shimoga Chandrashekar; Sooryanarayana Varambally; David J Gonzalez; A Catharine Ross; Matam Vijay-Kumar
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-03-23       Impact factor: 4.052

Review 6.  Parenteral Nutrition and Lipids.

Authors:  Maitreyi Raman; Abdulelah Almutairdi; Leanne Mulesa; Cathy Alberda; Colleen Beattie; Leah Gramlich
Journal:  Nutrients       Date:  2017-04-14       Impact factor: 5.717

Review 7.  Prevention and Treatment of Intestinal Failure-Associated Liver Disease in Children.

Authors:  Lorenzo Norsa; Emanuele Nicastro; Angelo Di Giorgio; Florence Lacaille; Lorenzo D'Antiga
Journal:  Nutrients       Date:  2018-05-24       Impact factor: 5.717

8.  The Impact of Glucose-Based or Lipid-Based Total Parenteral Nutrition on the Free Fatty Acids Profile in Critically Ill Patients.

Authors:  Pavel Skorepa; Ondrej Sobotka; Jan Vanek; Alena Ticha; Joao Fortunato; Jan Manak; Vladimir Blaha; Jan M Horacek; Lubos Sobotka
Journal:  Nutrients       Date:  2020-05-11       Impact factor: 5.717

Review 9.  Composition and Functionality of Lipid Emulsions in Parenteral Nutrition: Examining Evidence in Clinical Applications.

Authors:  Birinder Kaur Sadu Singh; Sreelakshmi Sankara Narayanan; Ban Hock Khor; Sharmela Sahathevan; Abdul Halim Abdul Gafor; Enrico Fiaccadori; Kalyana Sundram; Tilakavati Karupaiah
Journal:  Front Pharmacol       Date:  2020-04-29       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.